Clinical trials including the use of NP/TE conjugates are necessary to analyze whether the effect on the induction of CD4+ T memory central cell subset reduces the probability of recurrence in individuals with chronic ocular toxoplasmosis by stimulating the changes in the T-cell population mediating the immune response in these individuals. Here, CD4 is linked to ocular toxoplasmosis.